5-fluorodopamine has been researched along with Parkinson Disease in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eskola, O; Joutsa, J; Kaasinen, V; Rinne, JO | 1 |
| Bell, B; Buyan-Dent, L; Christian, BT; Gallagher, CL; Harding, SJ; Holden, JE; Johnson, SC; Nickles, RJ; Oh, J; Okonkwo, O; Palotti, M; Sojkova, J; Stone, CK | 1 |
| Bentho, O; Eldadah, BA; Goldstein, DS; Grossman, E; Holmes, C; Imrich, R; Pechnik, S; Sharabi, Y | 1 |
| Goldstein, DS; Holmes, C; Park, MY; Sewell, L; Sharabi, Y | 1 |
| Goldstein, DS | 2 |
| Dendi, R; Goldstein, DS; Holmes, C; Li, ST | 1 |
| Crawley, A; Dendi, R; Goldstein, DS; Gwinn-Hardy, K; Hardy, J; Holmes, C; Li, ST; Sharabi, Y; Singleton, A | 1 |
| Cannon, RO; Eisenhofer, G; Goldstein, DS; Holmes, C; Kopin, IJ | 2 |
| Bruce, S; Cannon, RO; Goldstein, DS; Holmes, C; Li, ST; Metman, LV | 1 |
| Snow, BJ | 1 |
2 review(s) available for 5-fluorodopamine and Parkinson Disease
| Article | Year |
|---|---|
Cardiac sympathetic neuroimaging to distinguish multiple system atrophy from Parkinson disease.
Topics: 3-Iodobenzylguanidine; Diagnosis, Differential; Dopamine; Fluorine Radioisotopes; Heart Conduction System; Humans; Multiple System Atrophy; Parkinson Disease; Radiopharmaceuticals; Sympathetic Nervous System | 2001 |
Positron emission tomography in Parkinson's disease.
Topics: Deoxyglucose; Dopamine; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Tomography, Emission-Computed | 1992 |
10 other study(ies) available for 5-fluorodopamine and Parkinson Disease
| Article | Year |
|---|---|
Reduced striatal dopamine synthesis capacity is associated with symptoms of depression in patients with de novo unmedicated Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Depression; Diagnostic and Statistical Manual of Mental Disorders; Dopamine; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neostriatum; Neurologic Examination; Parkinson Disease; Positron-Emission Tomography; Receptors, Presynaptic; Tomography, Emission-Computed, Single-Photon | 2013 |
Anterior cingulate dopamine turnover and behavior change in Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzophenones; Carbidopa; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Dopamine; Female; Gyrus Cinguli; Humans; Male; Middle Aged; Neuropsychological Tests; Nitrophenols; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Tolcapone | 2015 |
Functional effects of cardiac sympathetic denervation in neurogenic orthostatic hypotension.
Topics: Adrenergic beta-Agonists; Aged; Autonomic Nervous System Diseases; Blood Pressure; Dopamine; Female; Heart; Hemodynamics; Humans; Hypotension, Orthostatic; Isoproterenol; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Parkinson Disease; Radionuclide Imaging; Statistics, Nonparametric; Sympathectomy; Sympathomimetics; Tyramine | 2009 |
Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy.
Topics: Aged; alpha-Synuclein; Autonomic Denervation; Dementia; Dihydroxyphenylalanine; Disease Progression; Dopamine; Dopaminergic Neurons; Gait Disorders, Neurologic; Hallucinations; Humans; Lewy Body Disease; Male; Neostriatum; Norepinephrine; Parkinson Disease; Radiopharmaceuticals; Shy-Drager Syndrome; Sympathetic Nervous System | 2012 |
Patients as a scientific resource: comments on receiving the Ahrens award.
Topics: Awards and Prizes; Biomedical Research; Dopamine; Health Resources; Humans; National Institutes of Health (U.S.); Parkinson Disease; Patient-Centered Care; Translational Research, Biomedical; United States | 2011 |
Progressive loss of cardiac sympathetic innervation in Parkinson's disease.
Topics: Disease Progression; Dopamine; Fluorine Radioisotopes; Heart Conduction System; Humans; Hypotension, Orthostatic; Middle Aged; Parkinson Disease; Sympathetic Nervous System; Tomography, Emission-Computed | 2002 |
Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication.
Topics: Aged; alpha-Synuclein; Autonomic Nervous System Diseases; Dopamine; Heart; Humans; Hypotension, Orthostatic; Middle Aged; Mutation; Nerve Tissue Proteins; Parkinson Disease; Pedigree; Synucleins; Tomography, Emission-Computed; Valsalva Maneuver | 2004 |
Sympathetic cardioneuropathy in dysautonomias.
Topics: Adult; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Diagnosis, Differential; Dopamine; Fluorine Radioisotopes; Heart; Humans; Levodopa; Middle Aged; Myocardium; Norepinephrine; Parasympathetic Nervous System; Parkinson Disease; Reference Values; Shy-Drager Syndrome; Sympathetic Nervous System; Tomography, Emission-Computed | 1997 |
Sympathetic cardioneuropathy in dysautonomias.
Topics: Ammonia; Autonomic Nervous System Diseases; Coronary Circulation; Dopamine; Epinephrine; Fluorine Radioisotopes; Heart; Humans; Nitrogen Radioisotopes; Norepinephrine; Parkinson Disease; Shy-Drager Syndrome; Sympathetic Nervous System; Tomography, Emission-Computed | 1998 |
Cardiac sympathetic denervation in Parkinson disease.
Topics: Adult; Aged; Blood Pressure; Brain; Cardiac Catheterization; Diagnosis, Differential; Dopamine; Female; Fluorine Radioisotopes; Heart; Heart Rate; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Myocardium; Norepinephrine; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Tritium; Valsalva Maneuver | 2000 |